A conference connecting fundamental cancer research from molecules and cells to tissues, organs and whole organisms. Sessions cover molecular mechanisms, enabling technologies, cell behaviour, and cancer’s interactions with immunity, metabolism and its environment. Early-career and established researchers can develop interdisciplinary collaborations; poster sessions and selected lightning talks provide opportunities to present research. Abstracts close on 30 October 2026, with decisions from 13 November. Early-bird rates ended on 11 September; standard rates apply through 27 November, followed
Jan 25–26, 2027